Form 4: HeartBeam Director Sells Shares for Tax Obligations

HeartBeam Director George de Urioste sold 57,146 shares of common stock in two transactions to cover tax withholding obligations related to RSU vesting.

Summary

• George de Urioste, a Director of HeartBeam, Inc. (BEAT), reported two sales of common stock.
• On December 17, 2025, 23,961 shares were sold at a weighted average price of $3.68 per share.
• On December 18, 2025, an additional 33,185 shares were sold at a weighted average price of $2.83 per share.
• The total number of shares sold across both transactions was 57,146.
• These sales were conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• The RSUs vested on June 12, 2024, coinciding with the Issuer's 2024 annual meeting of stockholders.
• Following these transactions, George de Urioste's direct beneficial ownership of HeartBeam common stock is 0 shares.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: Neutral. While insider sales can sometimes be viewed negatively, these were explicitly for tax obligations and pre-planned under a 10b5-1 plan, which mitigates concerns about discretionary selling based on negative company news. The drop in price between the two sale dates is a minor negative.

Positives

• The sales were pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to managing equity compensation rather than a discretionary sale based on new negative information.
• The sales were specifically for covering tax withholding obligations, which is a common and expected event for RSU vesting.

Negatives

• A director's sale of a significant number of shares, even for tax purposes, can sometimes be perceived negatively by the market, especially if it results in zero direct beneficial ownership.
• The sale price on December 18, 2025 ($2.83) was notably lower than the sale price on December 17, 2025 ($3.68), indicating a decline in the stock price over a short period.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it pertains solely to an insider transaction.

Industry Context

This insider transaction is a routine disclosure for equity compensation and does not directly reflect broader industry trends. However, the stock price movement between the two sale dates could be influenced by general market conditions or company-specific news during that period.

Related Party Transactions

• The reported transactions involve a director of HeartBeam, Inc. selling company common stock, which is a related party transaction.

Stakeholder Impact

• Shareholders: May perceive the sale as a slight negative due to a director reducing their direct holdings, but the 10b5-1 plan and tax-related reason mitigate significant concern. The stock price decline between the two sale dates could be a concern.
• Employees, Customers, Suppliers, Creditors: Unlikely to have a direct impact from this specific filing.

Key Dates

Recommendation

The Form 4 filing details a director's sale of shares to cover tax obligations from RSU vesting, executed under a Rule 10b5-1 plan. This is a routine event and does not signal a change in the company's fundamentals or a lack of confidence from the director. While the director's direct beneficial ownership is now zero, the pre-planned nature and tax-related reason for the sale suggest a neutral impact on investment thesis. The slight decline in sale price between the two transaction dates is noted but not sufficient to warrant a 'sell' recommendation based solely on this filing. Investors should 'hold' and look for further operational updates from HeartBeam.

Keywords

HeartBeam, BEAT, Form 4, Insider Sale, George de Urioste, Director, Stock Sale, RSU Vesting, Tax Withholding, Equity Compensation, Rule 10b5-1